Xiaojun Xia

26PUBLICATIONS
105CO-AUTHORS
Molecular targetsInnate immunityTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Neural engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 02, 2026
Mevalonate pathway rewiring driven by enhancer remodelling confers resistance to KRAS inhibitors in colorectal cancer.

|Apr 27, 2026
An mRNA Tumor Nanovaccine Expressing Tumor Antigen Fused With Angiotensin II Facilitates Type 1 Conventional Dendritic Cell-Mediated Anti-Tumor Immunity.

|Feb 09, 2026
STING synergizes with TOX suppressing HO-1 expression to trigger ferroptosis in tumor-infiltrating CD8+ T cell and immunotherapy resistance.

Qian Zhu, Jun-Bao Zhang, Cai-Ping Nie

|Dec 09, 2025
Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ-IRF1-SREBF2 Axis.

Liping Xu, Xiaomin Zhang, Xiaowei Lai

|Sep 27, 2025
TCR-T Cell Recognition of an NY-ESO-1 Epitope Presented by HLA-A2 Supertype: Implications for Cancer Immunotherapy.

Qingqing Lin, Fenglan Liu, Yipeng Ma

|Sep 08, 2025
Aurora kinase A promotes trained immunity via regulation of endogenous S-adenosylmethionine metabolism.

Mengyun Li, Huan Jin, Yongxiang Liu

Pageof 5

Frequent Collaborators

3 joint publications

Zining Wang

3 joint publications

Jinyun Liu

2 joint publications

Peng Huang

2 joint publications

Song Gao